HomeMy HighlightsDiscover
Sign up

App

  • Chrome Extension
  • Safari Extension
  • iOS App
  • Android App

AI & Summary

  • YouTube Summary
  • PDF Summary
  • Webpage Summary
  • Audio Summary
  • Idea Hatch
  • AI Clone

Highlight Importer

  • Kindle Highlights
  • Pocket Highlights
  • Instapaper Highlights
  • Medium Highlights
  • Readwise Highlights
  • Hypothesis Highlights

Audio

  • Audio Transcriber

Image

  • Image Highlight
  • Quote Shots

Reading

  • Glasp Reader
  • Web & PDF Highlighter

Company

  • About us
  • API
  • Blog
  • Community
  • Job Board
  • FAQs
  • Newsletter
  • Pricing
Terms

•

Privacy

•

Guidelines

© 2025 Glasp Inc. All rights reserved.

Frontiers | Diabetic retinopathy: Looking forward to 2030 thumbnail
Frontiers | Diabetic retinopathy: Looking forward to 2030
www.frontiersin.org
flibercept (8 mg), sustained delivery of ranibizumab through a refillable port delivery system (PDS), and gene therapy with agents such as RGX-314 and ADVM-022 for long-term VEGF suppression (
1 Users
0 Comments
1 Highlights
0 Notes

Top Highlights

  • flibercept (8 mg), sustained delivery of ranibizumab through a refillable port delivery system (PDS), and gene therapy with agents such as RGX-314 and ADVM-022 for long-term VEGF suppression (

Domain

www.frontiersin.org

Ready to highlight and find good content?

Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.